MedTrace Logo

UVA1 Phototherapy in Acral Vitiligo

NCT03378011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-12-19

No results posted yet for this study

Summary

evaluate the effect of UVA1 phototherapy in the treatment of acral vitiligo.

Conditions

  • Acral Vitiligo

Interventions

OTHER

phototherapy

phototherapy either UVA1 or topical PUVA on acral vitiligo

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Maha Elmasry · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378011 on ClinicalTrials.gov